Medical News

RSS
Eisai's LUSEDRA Injection now available for MAC sedation

Eisai's LUSEDRA Injection now available for MAC sedation

Update from Novo Nordisk regarding its share repurchase programme

Update from Novo Nordisk regarding its share repurchase programme

Decision Resources: Neuropathic pain drug market to be $9.7B in 2018

Decision Resources: Neuropathic pain drug market to be $9.7B in 2018

Bravo Health to open its first Advanced Care Center in Philadelphia

Bravo Health to open its first Advanced Care Center in Philadelphia

Semafore Pharmaceuticals to present SF1126 Phase I data at the 51st ASH meeting

Semafore Pharmaceuticals to present SF1126 Phase I data at the 51st ASH meeting

Benenden selects Databarracks for online backup service

Benenden selects Databarracks for online backup service

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Neogen's Board of Directors approves a 3-for-2 stock split

Neogen's Board of Directors approves a 3-for-2 stock split

Seattle Genetics commences phase I clinical trial of SGN-75 ADC for metastatic renal cell carcinoma

Seattle Genetics commences phase I clinical trial of SGN-75 ADC for metastatic renal cell carcinoma

Researchers, decision makers, and people with HIV to attend Ontario HIV Treatment Network's conference

Researchers, decision makers, and people with HIV to attend Ontario HIV Treatment Network's conference

Eyes turn to Lieberman, Reid, Snowe as most crucial health reform players

Eyes turn to Lieberman, Reid, Snowe as most crucial health reform players

Brookstone Pharmaceuticals changes its name to Acella Pharmaceuticals

Brookstone Pharmaceuticals changes its name to Acella Pharmaceuticals

Third-quarter fiscal 2009 results announced by GeneLink

Third-quarter fiscal 2009 results announced by GeneLink

New mobile yoga class app for iPhone and iPod Touch iPractice 2.0 released

New mobile yoga class app for iPhone and iPod Touch iPractice 2.0 released

Electronic health records not yet making impact, patients turn to web for advice

Electronic health records not yet making impact, patients turn to web for advice

Interim data from Hollis-Eden Pharmaceuticals' Apoptone Phase I/II clinical trial presented

Interim data from Hollis-Eden Pharmaceuticals' Apoptone Phase I/II clinical trial presented

4SC raises funds for further development of its current product pipeline

4SC raises funds for further development of its current product pipeline

Health lobbying ranges from below the radar to high profile

Health lobbying ranges from below the radar to high profile

Drug makers hike prices, lobby hard as reform efforts progress

Drug makers hike prices, lobby hard as reform efforts progress

Onyx Pharmaceuticals acquires Proteolix

Onyx Pharmaceuticals acquires Proteolix

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.